S. Sean Tu

S. Sean Tu

Opinion author

S. Sean Tu is a professor at West Virginia University College of Law and a nationally recognized expert on patent law and drug law.

AbbVie’s blockbuster Humira held 105 patents, shielding the anti-inflammatory drug from biosimilar competition for more than 20 years. Proposed reforms could help prevent companies from extending exclusivity with such patent thickets.